Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Custirsen: Mechanism of action, Side effects & Pharmacokinetics

Custirsen (also known as OGX-011 and CC-8490), usually supplied as its sodium salt, is an investigational drug that is under clinical testing for the treatment of cancer. It is an antisense oligonucleotide (ASO) targeting clusterin expression. In metastatic prostate cancer, custirsen showed no benefit in improving overall survival.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Custirsen topic overview

The analysis highlights Mechanism of action, Side effects and Pharmacokinetics as prominent areas in the source structure around Custirsen.

Related topics
39
Source areas
4
Connected nodes
43
Extracted relationships
23
Related term clusters
8
Bridge connections
43

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Mechanism of action · 19 topics
Side effects · 11 topics
Pharmacokinetics · 5 topics
Overview · 4 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

CAS Number
890056-27-6
ChemSpider
34983386
DrugBank
DB05487
Formula
C231H312N78O119P20S20
Molar mass
7346.14 g·mol−1
Other names
OGX-011, CC-8490

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Custirsen
3Sodium · Oligonucleotide · Clusterin
5Antisense oligonucleotide · Complementary DNA · Messenger RNA
7Downregulation and upregulation · Apoptosis · Chemotherapy

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Mechanism of action

Pharmacokinetics

Side effects

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Custirsen connects Entity context

The extracted context around Custirsen shows recurring relationship patterns in the source. For example, Custirsen → Contrasting, Custirsen-independent, Docetaxel, Phase III, Prednisone, Researchers, The Phase III SYNERGY Another extracted example is Custirsen → Antisense, ASO, DNA, Phosphorothioates, RNA, Second-generation. Use these groups to spot repeated connection types before inspecting the individual relationships.

Custirsen

Top relations

related to Phase III Studies · 7
Custirsen → Contrasting, Custirsen-independent, Docetaxel, Phase III, Prednisone, Researchers, The Phase III SYNERGY
related to Mechanism of action · 6
Custirsen → Antisense, ASO, DNA, Phosphorothioates, RNA, Second-generation
CAS Number · 1
Custirsen → 890056-27-6
ChemSpider · 1
Custirsen → 34983386
DrugBank · 1
Custirsen → DB05487
Formula · 1
Custirsen → C231H312N78O119P20S20
Molar mass · 1
Custirsen → 7346.14 g·mol−1
Other names · 1
Custirsen → OGX-011, CC-8490
UNII · 1
Custirsen → L26E95NLRK
is a · 1
Custirsen → second-generation phosphorothioate antisense oligonucleotide

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

clusterin cancer drug mg studies dose antisense prostate phase study 640 also treatment mrna gene plasma protein increased patients found

Custirsen relationships Subject–Predicate–Object triples

TTTA extracted 23 structured relationships around Custirsen. Examples in this analysis include Custirsen → CAS Number → 890056-27-6 and Custirsen → ChemSpider → 34983386. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
CustirsenCAS Number890056-27-61.00infobox
CustirsenChemSpider349833861.00infobox
CustirsenDrugBankDB054871.00infobox
CustirsenFormulaC231H312N78O119P20S201.00infobox
CustirsenMolar mass7346.14 g·mol−11.00infobox
CustirsenOther namesOGX-011, CC-84901.00infobox
CustirsenUNIIL26E95NLRK1.00infobox
Custirsenis asecond-generation phosphorothioate antisense oligonucleotide0.90text
Custirsenhas effectPhase0.60section
Custirsenrelated to Mechanism of actionASO0.60section
Custirsenrelated to Mechanism of actionDNA0.60section
Custirsenrelated to Mechanism of actionRNA0.60section

Related concept clusters Related term clusters

The concept neighborhoods around Custirsen bring nearby vocabulary together. In this analysis, examples include Phase, Studies and Clusterin. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Custirsen
    • Phase
    • Studies
    • Clusterin
    • Patients
    • Treatment
    • Prostate
    • Dose
    • Cancer
    • Mg
    • Iii
    • Plasma
    • Study
  • custirsen
    • Phase
    • Studies
    • Clusterin
    • Patients
    • Treatment
    • Prostate
    • Dose
    • Cancer
    • Mg
    • Iii
    • Plasma
    • Study
  • clusterin
    • Concentrations
    • Plasma
    • Prostate
    • Custirsen
    • Activity
    • Adverse
    • Binding
    • Tumours
    • Gene
    • Patients
    • Protein
    • Phase
  • antisense oligonucleotide
    • Aso
    • Oligonucleotide
    • Mrna
    • Sequence
    • Cc-8490
    • Ogx-011
    • Activity
    • Binding
    • Iii
    • Oligonucleotides
    • Phase
    • Gene
  • antisense therapy
    • Aso
    • Oligonucleotide
    • Mrna
    • Cc-8490
    • Ogx-011
    • Activity
    • Binding
    • Iii
    • Oligonucleotides
    • Sequence
    • Gene
    • Increased
  • meta-analysis study
    • Studies
    • Clinical
    • Mg
    • Dose
    • Custirsen
    • Activity
    • Binding
    • Concentrations
    • Including
    • Found
    • Patients
    • Plasma
  • chemotherapy
    • Iii
    • Treatment
    • Phase
    • Including
    • Increased
    • Patients
    • Prostate
    • Dose
    • Studies
    • Mg
    • Custirsen
    • Clusterin
  • pro-apoptotic blc2 gene
    • Binding
    • Concentrations
    • Increased
    • Mrna
    • Protein
    • Adverse
    • Including
    • Oligonucleotides
    • Sequence
    • Tumours
    • Plasma
    • Prostate

Connections between topic areas Semantic bridges

For Custirsen, one of the stronger structural bridges in this analysis connects Custirsen with Mechanism of action. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
Custirsen — Mechanism of action · splits 24 ⟂ 20
Custirsen — Side effects · splits 32 ⟂ 12
Custirsen — Pharmacokinetics · splits 38 ⟂ 6
Custirsen — Overview · splits 39 ⟂ 5

Map overview Semantic statistics

Custirsen

Nodes44
Edges43
Triples23
Avg. degree1.95
Density0.045455
Components1

Source & methodology

TTTA analyzes the structure around Custirsen to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Mechanism of action, Side effects & Pharmacokinetics, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Custirsen · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.

Monitor your Domain Rating with FrogDR